← FDA Drug Approvals (Drugs@FDA)

IQIRVO

NDA · New Drug Application · Sponsor: IPSEN · Approved 2024-06-10

Drug application

FDA Application #

NDA218860

Application type

New Drug Application

Brand name

IQIRVO

Generic name

ELAFIBRANOR

Active ingredients

ELAFIBRANOR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

IPSEN

Manufacturer

Ipsen Biopharmaceuticals, Inc.

First approval

2024-06-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown